Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Metal Nanoparticles Released from Dental Implant Surfaces: Potential Contribution to Chronic Inflammation and Peri-Implant Bone Loss.

Bressan E, Ferroni L, Gardin C, Bellin G, Sbricoli L, Sivolella S, Brunello G, Schwartz-Arad D, Mijiritsky E, Penarrocha M, Penarrocha D, Taccioli C, Tatullo M, Piattelli A, Zavan B.

Materials (Basel). 2019 Jun 25;12(12). pii: E2036. doi: 10.3390/ma12122036.

2.

Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.

Fong LY, Jing R, Smalley KJ, Wang ZX, Taccioli C, Fan S, Chen H, Alder H, Huebner K, Farber JL, Fiehn O, Croce CM.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11091-E11100. doi: 10.1073/pnas.1813956115. Epub 2018 Nov 5.

3.

Impact of non-LTR retrotransposons in the differentiation and evolution of anatomically modern humans.

Guichard E, Peona V, Malagoli Tagliazucchi G, Abitante L, Jagoda E, Musella M, Ricci M, Rubio-Roldán A, Sarno S, Luiselli D, Pettener D, Taccioli C, Pagani L, Garcia-Perez JL, Boattini A.

Mob DNA. 2018 Aug 15;9:28. doi: 10.1186/s13100-018-0133-4. eCollection 2018.

4.

Correction to: Transposable Elements Activity is Positively Related to Rate of Speciation in Mammals.

Ricci M, Peona V, Guichard E, Taccioli C, Boattini A.

J Mol Evol. 2018 Jun;86(5):311. doi: 10.1007/s00239-018-9850-z.

5.

Transposable Elements Activity is Positively Related to Rate of Speciation in Mammals.

Ricci M, Peona V, Guichard E, Taccioli C, Boattini A.

J Mol Evol. 2018 Jun;86(5):303-310. doi: 10.1007/s00239-018-9847-7. Epub 2018 May 31. Erratum in: J Mol Evol. 2018 Jun 25;:.

6.

An Ultraconserved Element Containing lncRNA Preserves Transcriptional Dynamics and Maintains ESC Self-Renewal.

Fiorenzano A, Pascale E, Gagliardi M, Terreri S, Papa M, Andolfi G, Galasso M, Tagliazucchi GM, Taccioli C, Patriarca EJ, Cimmino A, Matarazzo MR, Minchiotti G, Fico A.

Stem Cell Reports. 2018 Mar 13;10(3):1102-1114. doi: 10.1016/j.stemcr.2018.01.014. Epub 2018 Feb 15.

7.

Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia.

Fong LY, Jing R, Smalley KJ, Taccioli C, Fahrmann J, Barupal DK, Alder H, Farber JL, Fiehn O, Croce CM.

Oncotarget. 2017 Jun 9;8(47):81910-81925. doi: 10.18632/oncotarget.18434. eCollection 2017 Oct 10.

8.

Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.

Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM.

Cancer Cell. 2016 Aug 8;30(2):349-351. doi: 10.1016/j.ccell.2016.07.007. Epub 2016 Aug 8. No abstract available.

9.

MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency.

Fong LY, Taccioli C, Jing R, Smalley KJ, Alder H, Jiang Y, Fadda P, Farber JL, Croce CM.

Oncotarget. 2016 Mar 8;7(10):10723-38. doi: 10.18632/oncotarget.7561.

10.

MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells.

Taccioli C, Sorrentino G, Zannini A, Caroli J, Beneventano D, Anderlucci L, Lolli M, Bicciato S, Del Sal G.

Oncotarget. 2015 Nov 17;6(36):38854-65. doi: 10.18632/oncotarget.5749.

11.

APTANI: a computational tool to select aptamers through sequence-structure motif analysis of HT-SELEX data.

Caroli J, Taccioli C, De La Fuente A, Serafini P, Bicciato S.

Bioinformatics. 2016 Jan 15;32(2):161-4. doi: 10.1093/bioinformatics/btv545. Epub 2015 Sep 22.

PMID:
26395772
12.

Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo.

Taccioli C, Garofalo M, Chen H, Jiang Y, Tagliazucchi GM, Di Leva G, Alder H, Fadda P, Middleton J, Smalley KJ, Selmi T, Naidu S, Farber JL, Croce CM, Fong LY.

J Natl Cancer Inst. 2015 Aug 18;107(11). pii: djv220. doi: 10.1093/jnci/djv220. Print 2015 Nov.

13.

The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.

García-Cruz R, Camats M, Calin GA, Liu CG, Volinia S, Taccioli C, Croce CM, Bach-Elias M.

BMC Med Genet. 2015 Jul 3;16:46. doi: 10.1186/s12881-015-0184-z.

14.

Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation.

Cieri N, Oliveira G, Greco R, Forcato M, Taccioli C, Cianciotti B, Valtolina V, Noviello M, Vago L, Bondanza A, Lunghi F, Marktel S, Bellio L, Bordignon C, Bicciato S, Peccatori J, Ciceri F, Bonini C.

Blood. 2015 Apr 30;125(18):2865-74. doi: 10.1182/blood-2014-11-608539. Epub 2015 Mar 3.

PMID:
25736310
15.

UCbase 2.0: ultraconserved sequences database (2014 update).

Lomonaco V, Martoglia R, Mandreoli F, Anderlucci L, Emmett W, Bicciato S, Taccioli C.

Database (Oxford). 2014 Jun 19;2014. pii: bau062. doi: 10.1093/database/bau062. Print 2014.

16.

Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.

Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CM.

PLoS Genet. 2013;9(3):e1003311. doi: 10.1371/journal.pgen.1003311. Epub 2013 Mar 7. Erratum in: PLoS Genet. 2013 Apr;9(4). doi:10.1371/annotation/92dfa670-d431-4d68-b70b-706df1f93e46. Ramasamy, Santhanam [corrected to Santhanam, Ramasamy].

17.

Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.

Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM.

Oncogene. 2014 Feb 6;33(6):702-12. doi: 10.1038/onc.2013.13. Epub 2013 Feb 18.

18.

Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference.

Visani M, de Biase D, Marucci G, Taccioli C, Baruzzi A, Pession A; PERNO Study Group.

PLoS One. 2013;8(1):e55314. doi: 10.1371/journal.pone.0055314. Epub 2013 Jan 29.

19.

Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer.

Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, Fong LY.

Carcinogenesis. 2012 Sep;33(9):1736-44. doi: 10.1093/carcin/bgs204. Epub 2012 Jun 10.

20.

Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer.

Piovan C, Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CM.

Mol Oncol. 2012 Aug;6(4):458-72. doi: 10.1016/j.molonc.2012.03.003. Epub 2012 Apr 19.

21.

miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR.

de Biase D, Visani M, Morandi L, Marucci G, Taccioli C, Cerasoli S, Baruzzi A, Pession A; PERNO Study Group.

PLoS One. 2012;7(4):e35596. doi: 10.1371/journal.pone.0035596. Epub 2012 Apr 18.

22.

Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature.

Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ, Farber JL, Croce CM, Fong LY.

Oncogene. 2012 Oct 18;31(42):4550-8. doi: 10.1038/onc.2011.592. Epub 2011 Dec 19.

23.

miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.

Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ, Croce CM.

Blood. 2011 Sep 15;118(11):3072-9. doi: 10.1182/blood-2011-01-333484. Epub 2011 Jun 2.

24.

ParkDB: a Parkinson's disease gene expression database.

Taccioli C, Tegnér J, Maselli V, Gomez-Cabrero D, Altobelli G, Emmett W, Lescai F, Gustincich S, Stupka E.

Database (Oxford). 2011 May 18;2011:bar007. doi: 10.1093/database/bar007. Print 2011.

25.

A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor.

Thompson LH, Whiston RA, Rakhimov Y, Taccioli C, Liu CG, Croce C, Metcalfe SM.

Cell Cycle. 2010 Oct 15;9(20):4213-21. Epub 2010 Oct 4.

26.

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development.

Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM.

Cancer Cell. 2010 Oct 19;18(4):367-81. doi: 10.1016/j.ccr.2010.09.005. Erratum in: Cancer Cell. 2016 Aug 8;30(2):349-351.

27.

Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression.

Wan SG, Taccioli C, Jiang Y, Chen H, Smalley KJ, Huang K, Liu XP, Farber JL, Croce CM, Fong LY.

Int J Cancer. 2011 Jul 15;129(2):331-45. doi: 10.1002/ijc.25688. Epub 2010 Nov 9.

28.

GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials.

Tili E, Michaille JJ, Liu CG, Alder H, Taccioli C, Volinia S, Calin GA, Croce CM.

Nucleic Acids Res. 2010 Nov;38(21):7673-88. doi: 10.1093/nar/gkq637. Epub 2010 Jul 17.

29.

Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.

Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM.

Carcinogenesis. 2010 Sep;31(9):1561-6. doi: 10.1093/carcin/bgq143. Epub 2010 Jul 9.

30.

Reprogramming of miRNA networks in cancer and leukemia.

Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM.

Genome Res. 2010 May;20(5):589-99. doi: 10.1101/gr.098046.109.

31.

MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.

Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM.

J Natl Cancer Inst. 2010 May 19;102(10):706-21. doi: 10.1093/jnci/djq102. Epub 2010 Apr 13.

32.

MicroRNA profiles of drug-resistant myeloma cell lines.

Munker R, Liu CG, Taccioli C, Alder H, Heerema N.

Acta Haematol. 2010;123(4):201-4. doi: 10.1159/000302889. Epub 2010 Mar 31. No abstract available.

33.

Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes.

Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G, Suzuki T, Croce CM, Patel T.

Clin Cancer Res. 2010 Feb 1;16(3):957-66. doi: 10.1158/1078-0432.CCR-09-2123. Epub 2010 Jan 26.

34.

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM.

Lancet Oncol. 2010 Feb;11(2):136-46. doi: 10.1016/S1470-2045(09)70343-2. Epub 2009 Dec 18.

35.

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM.

Cancer Cell. 2009 Dec 8;16(6):498-509. doi: 10.1016/j.ccr.2009.10.014.

36.

Karyotype-specific microRNA signature in chronic lymphocytic leukemia.

Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, Volinia S, Ferracin M, Palatini J, Balatti V, Alder H, Negrini M, Kipps TJ, Croce CM.

Blood. 2009 Oct 29;114(18):3872-9. doi: 10.1182/blood-2009-06-229211. Epub 2009 Aug 28.

37.

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.

Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia AJ, Secreto C, Wellik LE, Lee YK, Mukhopadhyay D, Kay NE.

Blood. 2009 May 28;113(22):5568-74. doi: 10.1182/blood-2008-10-185686. Epub 2009 Mar 31.

38.

Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat.

Taccioli C, Wan SG, Liu CG, Alder H, Volinia S, Farber JL, Croce CM, Fong LY.

Gastroenterology. 2009 Mar;136(3):953-66. doi: 10.1053/j.gastro.2008.11.039. Epub 2008 Nov 24.

39.

Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.

Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett W.

Blood. 2009 Apr 16;113(16):3744-53. doi: 10.1182/blood-2008-09-178707. Epub 2008 Dec 18.

40.

BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.

Quaresima B, Romeo F, Faniello MC, Di Sanzo M, Liu CG, Lavecchia A, Taccioli C, Gaudio E, Baudi F, Trapasso F, Croce CM, Cuda G, Costanzo F.

Clin Cancer Res. 2008 Nov 1;14(21):6797-803. doi: 10.1158/1078-0432.CCR-07-5208.

41.

UCbase & miRfunc: a database of ultraconserved sequences and microRNA function.

Taccioli C, Fabbri E, Visone R, Volinia S, Calin GA, Fong LY, Gambari R, Bottoni A, Acunzo M, Hagan J, Iorio MV, Piovan C, Romano G, Croce CM.

Nucleic Acids Res. 2009 Jan;37(Database issue):D41-8. doi: 10.1093/nar/gkn702. Epub 2008 Oct 22.

42.

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.

Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12885-90. doi: 10.1073/pnas.0806202105. Epub 2008 Aug 26.

43.

MiR-15a and miR-16-1 cluster functions in human leukemia.

Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CM.

Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5166-71. doi: 10.1073/pnas.0800121105. Epub 2008 Mar 24.

44.

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.

Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM, Condorelli G.

Oncogene. 2008 Jun 19;27(27):3845-55. doi: 10.1038/onc.2008.6. Epub 2008 Feb 4.

PMID:
18246122
45.

Compatible solutes from hyperthermophiles improve the quality of DNA microarrays.

Mascellani N, Liu X, Rossi S, Marchesini J, Valentini D, Arcelli D, Taccioli C, Helmer Citterich M, Liu CG, Evangelisti R, Russo G, Santos JM, Croce CM, Volinia S.

BMC Biotechnol. 2007 Nov 23;7:82.

46.

MicroRNA signatures in human ovarian cancer.

Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM.

Cancer Res. 2007 Sep 15;67(18):8699-707.

47.

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.

Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM.

Cancer Cell. 2007 Sep;12(3):215-29.

48.

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM.

JAMA. 2007 May 2;297(17):1901-8.

PMID:
17473300

Supplemental Content

Loading ...
Support Center